Moneycontrol
Get App
Last Updated : Jul 12, 2019 05:00 PM IST | Source: Moneycontrol.com

Glenmark Pharma Q1 PAT may dip 44.8% YoY to Rs. 151.7 cr: Prabhudas Lilladher

Net Sales are expected to increase by 5.6 percent Y-o-Y (down 11 percent Q-o-Q) to Rs. 2,247.9 crore, according to Prabhudas Lilladher.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its first quarter (April-June’ 19) earnings estimates for the Pharma sector. The brokerage house expects Glenmark Pharma to report net profit at Rs. 151.7 crore down 44.8% year-on-year (down 6.2% quarter-on-quarter).


Net Sales are expected to increase by 5.6 percent Y-o-Y (down 11 percent Q-o-Q) to Rs. 2,247.9 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 5.1 percent Y-o-Y (down 9.7 percent Q-o-Q) to Rs. 294.9 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.




Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Jul 12, 2019 05:00 pm
Sections
Follow us on